Higher doses of levetiracetam evaluated for efficacy and, particularly, tolerability in epileptics June 21, 1999
New class of tachykinin antagonists synthesized at MS&D, particularly useful for emesis June 18, 1999
Selective M1 receptor agonist chosen for further study under Novo Nordisk/Lilly collaboration June 17, 1999